To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. (HR-6837) · Congress.wiki

To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. (HR-6837) · Congress.wiki

Pros & Cons

The bill aims to lower drug costs and improve PBM accountability through ERISA fiduciary duties, transparency, and stronger enforcement, but those benefits could come with higher compliance costs, market consolidation, and short-term disruptions that may raise premiums or reduce plan options for some Americans.

Potential Benefits

3

Patients (especially those with chronic conditions) and plan participants could see lower out-of-pocket drug costs and better-aligned PBM incentives because PBMs would be held to ERISA fiduciary duties requiring loyalty and best-price conduct when negotiating rebates and formularies.
Health & Safety
patients-chronic-conditions, medicare-beneficiaries, medicaid-beneficiaries, plan participants
Plan sponsors, state governments, and health systems would get greater transparency about PBM arrangements (limiting when covered service providers can be treated as the responsible fiduciary for disclosure), improving oversight of drug pricing and plan design.
Government
plan sponsors, state-governments, hospitals-health-systems
Participants and plan sponsors would have stronger enforcement options and easier legal recourse because the bill prohibits indemnification that would shield PBMs from ERISA liability, making it simpler to pursue fiduciary breaches.
Justice
patients-chronic-conditions, plan sponsors, plan participants

Potential Drawbacks

4

Middle-class families, small-business owners, and taxpayers could face higher premiums or employer health-plan costs if PBMs and insurers raise administrative fees or shift costs to plans to cover increased compliance and legal exposure.
Economy
middle-class-families, small-business-owners, taxpayers
Smaller PBMs or third-party administrators may exit the market or be acquired, reducing competition and potentially increasing long-term costs for some plans and families.
Economy
small-business-owners, middle-class-families, plan sponsors
Some PBM services could be curtailed or vertically restructured if firms avoid activities that would trigger fiduciary status, reducing plan options and altering competitive models available to state governments, hospitals, and employers.
Economy
state-governments, hospitals-health-systems, plan sponsors

Based on analysis of 2 sections of legislative text.

Bill Summary

Summary

Designates pharmacy benefit managers (PBMs) and similar entities as ERISA fiduciaries for employer-sponsored group health plans when they set or manage drug networks/formularies, negotiate or aggregate rebates or other price concessions, process and pay prescription drug claims, or perform drug utilization review/management. It also prevents contracts from indemnifying or shielding those newly deemed fiduciaries from ERISA liability and allows a PBM that sponsors a plan for its own employees to be treated as the responsible plan fiduciary for that specific plan. The changes modify ERISA fiduciary and disclosure rules and take effect for plan years that begin at least 12 months after enactment, with contract provisions that try to indemnify newly deemed fiduciaries declared void as against public policy.

Key Points

Click to see evidence